Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Mylan Joins Firms Facing DOJ Probe On Price Hikes; Senate Plans Industry-Free Hearing

This article was originally published in The Pink Sheet Daily

Executive Summary

Senate Special Aging Committee hearing Wednesday to focus on price spikes in off-patent drugs without testimony from drug makers.

Advertisement

Related Content

Generic Industry Hit With Avalanche Of Price Fixing Suits
Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors
Could Drug Price Spikes Spur ANDA Priority Reviews?
Gilead's Pricing Strategy Faces New Opposition Tactics: Patent, Antitrust Suit
Senate's Bipartisan Rx Pricing Probe Seeks Documents Regarding FDA Regs
PhRMA Takes Aim At Valeant In Defense Of Drug Pricing By ‘Innovative’ Firms

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register